Medicine
Safer painkillers: A novel drug treats pain without killing people
Painkillers have nasty side effects, such as organ damage or addiction. Researchers have discovered a new drug that may cause none of these.
Anti-aging isn’t a scam, but immortality almost certainly is
A new biotech firm with $3 billion in funding has announced plans to combat aging. But what does that mean for human life span, exactly?
Clues to schizophrenia and bipolar disorder hidden in the dark genome
A new study suggests that the causes of these disorders are hidden in "dark genes," which may account for the enigma of their development.
Moderna will develop mRNA vaccines for Ebola, malaria, other major threats
Moderna is developing mRNA vaccines for 15 “priority" pathogens and launching a program giving other developers access to its mRNA tech.
How the antidepressant Prozac could treat blindness
Prozac is a widely used antidepressant. Data indicates that the drug could be used to prevent blindness due to macular degeneration.
New antidepressant helps patients in just three days
Adding the new antidepressant zuranolone to standard treatments helped people with major depressive disorder feel better in less time.
90% of drugs fail clinical trials – here’s one way researchers can select better drug candidates
It’s disappointing when the years of effort and resources spent to push a drug candidate to patients so often lead to failure.
What the Russian invasion means for clinical trials in Ukraine
Russia’s invasion has the potential to disrupt clinical trials in Ukraine, warns one of the many companies staging trials in the nation.
How mRNA and DNA vaccines could treat autoimmune disorders, genetic diseases, and more
Using DNA or an mRNA vaccine, researchers are investigating the feasibility of essentially replacing missing genes that cause disease.
How close are we to curing blindness?
New approaches to curing blindness are heralding a future in which fewer people have to live life completely in the dark.